tiprankstipranks
Denali Therapeutics (DNLI)
NASDAQ:DNLI
Holding DNLI?
Track your performance easily

Denali Therapeutics (DNLI) Income Statement

624 Followers

Denali Therapeutics Income Statement

Last quarter (Q3 2024), Denali Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, Denali Therapeutics's net income was $-107.19M. See Denali Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 294.12M$ 330.53M$ 108.46M$ 48.66M$ 335.66M$ 26.68M
Cost of Revenue
------
Gross Profit
$ 294.12M$ 330.53M$ 108.46M$ 48.66M$ 335.66M-
Operating Expense
$ 495.99M$ 527.23M$ 449.21M$ 344.41M$ 272.94M$ 239.86M
Operating Income
$ -201.87M$ -196.70M$ -340.74M$ -295.75M$ 62.72M$ -213.18M
Net Non Operating Interest Income Expense
$ -5.04M$ -51.51M$ -14.77M--$ 15.22M
Other Income Expense
$ -26.03M$ -51.51M$ -18.17M$ -4.60M$ -9.34M-
Pretax Income
$ -142.28M$ -145.19M$ -325.97M$ -291.16M$ 71.96M$ -197.97M
Tax Provision
$ 30.00K$ 30.00K$ 21.00K$ -575.00K$ 823.00K$ -351.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -142.31M$ -145.22M$ -325.99M$ -290.58M$ 71.14M$ -197.61M
Basic EPS
$ -0.76$ -1.06$ -2.60$ -2.39$ 0.65$ -2.07
Diluted EPS
$ -0.76$ -1.06$ -2.60$ -2.39$ 0.63$ -2.07
Basic Average Shares
$ 613.60M$ 137.37M$ 125.53M$ 121.52M$ 108.97M$ 95.61M
Diluted Average Shares
$ 613.60M$ 137.37M$ 125.53M$ 121.52M$ 112.70M$ 95.61M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 495.99M$ 527.23M$ 449.21M$ 344.41M$ 272.94M$ 239.86M
Net Income From Continuing And Discontinued Operation
$ -142.31M$ -145.22M$ -325.99M$ -290.58M$ 71.14M$ -197.61M
Normalized Income
$ -98.04M----$ -197.61M
Interest Expense
------
EBIT
$ -201.87M$ -196.70M$ -340.74M$ -295.75M$ 62.72M$ -213.18M
EBITDA
$ -202.00M$ -179.97M$ -330.36M$ -287.16M$ 71.25M$ -205.19M
Currency in USD

Denali Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis